Change - Announcement of Appointment::Appointment as Independent Director

Issuer & Securities

Issuer/ Manager
KEPPEL CORPORATION LIMITED
Securities
KEPPEL CORPORATION LIMITED - SG1U68934629 - BN4
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
23-Jun-2021 17:51:44
Status
New
Announcement Sub Title
Appointment as Independent Director
Announcement Reference
SG210623OTHRLLN7
Submitted By (Co./ Ind. Name)
Caroline Chang/Kenny Lee
Designation
Company Secretaries
Description (Please provide a detailed description of the event in the box below)
Appointment as Independent Director

Additional Details

Date Of Appointment
01/07/2021
Name Of Person
Shirish Moreshwar Apte
Age
68
Country Of Principal Residence
Singapore
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process)
Having evaluated the balance and mix of skills, knowledge, experience and other aspects of diversity, and the size of the Board, and in consultation with Management, the Nominating Committee ("NC") of Keppel Corporation Limited ("KCL") shortlisted and met with some candidates to assess suitability and to ensure that the candidates were aware of the expectations and level of commitment required of a KCL Board member. The NC was of the view that Mr Shirish Apte would be a suitable addition to the Board as the Board would benefit from his expertise and experience on several fronts, including his ability to analyse organisational strategies, expertise in deal making and risk analysis, international experience and knowledge of, and experience and network in, India.

The Board having considered the recommendation from the NC, approved the appointment of Mr Shirish Apte as an Independent Director to the Board.
Whether appointment is executive, and if so, the area of responsibility
Non-executive
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Independent Director
Professional qualifications
1. Qualified as a Member of Institute of Chartered Accountants England and Wales; and
2. Member of the Institute of Chartered Accountants, India.
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
None
Conflict of interests (including any competing business)
None
Working experience and occupation(s) during the past 10 years
Chairman, Citigroup Asia Pacific Banking - 2012 to 2014
CEO, Citigroup Asia Pacific - 2009 to 2011

Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
No
Other Principal Commitments* Including Directorships#
*"Principal Commitments" has the same meaning as defined in the Code
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
1. IHH Healthcare Berhad, Malaysia
2. Acibadem Healthcare, Turkey
3. Intergrated Hospitals and Healthcare Bhd
4. Acibadem Healthcare, Turkey
5. Citi Bank Handlowy, Poland
6. CG Power & Industrial Solutions
Present
1. Commonwealth Bank of Australia
2. Fortis Healthcare Limited, India
3. Pierfront Capital Mezzanine Fund Pte Ltd
4. Clifford Capital Pte. Ltd.
5. Fullerton India Credit Company Limited, India
6. Pierfront Capital Fund Management Pte. Ltd.
7. KP Management (GL) Pte. Ltd.
8. KPCF Investments Pte. Ltd.
9. Clifford Capital Holdings Pte. Ltd.
10. Keppel Infrastructure Holdings Pte. Ltd.
11. Aviva Singlife Holdings Pte. Ltd.
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Disclosure applicable to the appointment of Director only.
Any prior experience as a director of an issuer listed on the Exchange?
Yes
If Yes, Please provide details of prior experience
Yes. Mr Shirish Apte was on the board of IHH Healthcare Berhad, which is listed on Main Board of the Exchange.

Attachments

MREL_Keppel Corporation appoints Shirish Apte to its Board.pdf
Total size =89K